Correspondence 0001193125-26-204013 from Vor Biopharma Inc. (VOR)
Vor Biopharma Inc.
Date: May 4, 2026 · CIK: 0001817229 · Accession: 0001193125-26-204013
AI Filing Summary & Sentiment
Reasoning
Letter
RE: Vor Biopharma Inc. Registration Statement on Form S-3 (File No. 333- 295346) Request for Acceleration of Effective Date Requested Date: May 6, 2026 Requested Time: 4:00 p.m. Eastern Time Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “ Registrant ”) hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333- 295346) (the “ Registration Statement ”) to become effective on May 6, 2026, at 4:00 p.m. Eastern Time, or as soon thereafter as is practicable. Once the Registration Statement has been declared effective, please orally confirm that event with Madison Jones of Cooley LLP, counsel to the Registrant, at (202) 728-7087, or in her absence, David Brinton at (202) 776-2989.
Vor Biopharma Inc. 500 Boylston Street, Suite 1350 Boston, MA 02116 May 4, 2026 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Tyler Howes
Very truly yours,
Vor Biopharma Inc.
Show Raw Text
CORRESP 1 filename1.htm CORRESP Vor Biopharma Inc. 500 Boylston Street, Suite 1350 Boston, MA 02116 May 4, 2026 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Tyler Howes RE: Vor Biopharma Inc. Registration Statement on Form S-3 (File No. 333- 295346) Request for Acceleration of Effective Date Requested Date: May 6, 2026 Requested Time: 4:00 p.m. Eastern Time Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “ Registrant ”) hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333- 295346) (the “ Registration Statement ”) to become effective on May 6, 2026, at 4:00 p.m. Eastern Time, or as soon thereafter as is practicable. Once the Registration Statement has been declared effective, please orally confirm that event with Madison Jones of Cooley LLP, counsel to the Registrant, at (202) 728-7087, or in her absence, David Brinton at (202) 776-2989. Very truly yours, Vor Biopharma Inc. By: /s/ Adi Osovsky Name: Adi Osovsky Title: General Counsel and Secretary